Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system
Open accessThe DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Abstract
Background: Cancer treatment with a variety of chemotherapeutic agents often is associated with delayed adverse neurological consequences. Despite their clinical importance, almost nothing is known about the basis for such effects. It is not even known whether the occurrence of delayed adverse effects requires exposure to multiple chemotherapeutic agents, the presence of both chemotherapeutic agents and the body's own response to cancer, prolonged damage to the blood-brain barrier, inflammation or other such changes. Nor are there any animal models that could enable the study of this important problem. Results: We found that clinically relevant concentrations of 5-fluorouracil (5-FU; a widely used chemotherapeutic agent) were toxic for both central nervous system (CNS) progenitor cells and non-dividing oligodendrocytes in vitro and in vivo. Short-term systemic administration of 5-FU caused both acute CNS damage and a syndrome of progressively worsening delayed damage to myelinated tracts of the CNS associated with altered transcriptional regulation in oligodendrocytes and extensive myelin pathology. Functional analysis also provided the first demonstration of delayed effects of chemotherapy on the latency of impulse conduction in the auditory system, offering the possibility of non-invasive analysis of myelin damage associated with cancer treatment. Conclusions: Our studies demonstrate that systemic treatment with a single chemotherapeutic agent, 5-FU, is sufficient to cause a syndrome of delayed CNS damage and provide the first animal model of delayed damage to white-matter tracts of individuals treated with systemic chemotherapy. Unlike that caused by local irradiation, the degeneration caused by 5-FU treatment did not correlate with either chronic inflammation or extensive vascular damage and appears to represent a new class of delayed degenerative damage in the CNS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 CNS progenitor cells are vulnerable to clinically relevant levels of 5-FU exposure. (a) A summary of the putative relationships between the different cell types under study (for discussion of this and alternative views on lineage relationships in the CNS, see [199,200]). Pluripotent neuroepithelial stem cells (NSC) give rise to glial restricted precursor (GRP) cells and neuron restricted precursor (NRP) cells. GRP cells in turn give rise to astrocytes and oligodendrocyte-type-2 astrocyte progenitor/oligodendrocyte precursor cells (O-2A/OPCs), the ancestors of oligodendrocytes. (b,c) Primary CNS cells (b) or various cancer cell lines (c) were grown on coverslips and exposed to 5-FU for 24 h before analysis of cell viability as described in Materials and methods. 5-FU concentrations were chosen on the basis of drug concentrations reached in humans after conventional 5-FU treatment. None of the tumor lines tested were sensitive to 5-FU treatment in this dose range, whereas O-2A/OPCs, oligodendrocytes, GRP cells and human umbilical vein endothelial cells (HUVECs) were sensitive. (d,e) Exposure conditions designed to mimic the exposure levels associated with long-term infusion (d) or high-dose bolus administration (e) yielded similar results, with vulnerability of O-2A/OPCs and non-dividing oligodendrocytes to 5-FU exceeding the vulnerability of rapidly dividing cancer cells. As shown in (b,d), the vulnerability of HUVECs also exceeds the vulnerability of cancer cells. Each experiment was carried out in quadruplicate and was repeated at least twice in independent experiments. Data represent mean of survival ± s.e.m, normalized to control values.](https://figures.cochat.ai/paper-figures/1e1e4baf61204ebcbcfb8ba9503ec507/systemic-5-fluorouracil-treatment-causes-a-syndrome-of-delayed-myelin-figure-1.jpg)










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mainstay of CRC treatment, 5‐fluorouracil, has several side effects, including toxicity to both central nervous system progenitor cells and oligodendrocytes, even in the short term, limiting its long‐term clinical use [31, 32].”
From Synergistic Potential of Argentatins A and B to Improve 5‐Fluorouracil Cytotoxicity in Colorectal Cancer Cell Models (2024) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subventricular zone astrocytes are neural stem cells in the adult mammalian brain
Doetsch, F., Caillé, I., Lim, D. A., García-Verdugo, J. M., & Alvarez-Buylla, A. (1999) · Cell · doi:10.1016/s0092-8674(00)80783-7 · Cited by 3,898 · cited 20×
“In the SVZ, 5-FU exposure was associated with a 40.9 ± 2.6% decrease in numbers of BrdU+ cells on day 1, with a transient re-population of BrdU+ cells at days 7 and 14, followed by a subsequent decrease in animals examined at day 56 and 6 months after completion of treatment.”
BackgroundMethodInfluentialInflammatory Blockade Restores Adult Hippocampal Neurogenesis
Monje, M. L., Toda, H., & Palmer, T. D. (2003) · Science · doi:10.1126/science.1088417 · Cited by 2,426
Raff, M. C., Miller, R. H., & Noble, M. (1983) · Nature · doi:10.1038/303390a0 · Cited by 2,030
Self-citationF4/80, a monoclonal antibody directed specifically against the mouse macrophage
Austyn, J. M., & Gordon, S. (1981) · European Journal of Immunology · doi:10.1002/eji.1830111013 · Cited by 1,579
Transient expression of doublecortin during adult neurogenesis
Brown, J. P., Couillard‐Després, S., Cooper‐Kuhn, C. M., Winkler, J., Aigner, L., & Kuhn, H. G. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10874 · Cited by 1,496
Neurogenesis in Adult Subventricular Zone
Alvarez-Buylla, A., & Garcı́a-Verdugo, J. M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00629.2002 · Cited by 1,466
Freireich, E. J., Gehan, E. A., Rall, D. P., Schmidt, L. H., & Skipper, H. E. (1966) · PubMed · Cited by 1,382
Irradiation induces neural precursor-cell dysfunction
Monje, M. L., Mizumatsu, S., Fike, J. R., & Palmer, T. D. (2002) · Nature Medicine · doi:10.1038/nm749 · Cited by 1,271
Clinical Pharmacology of 5-Fluorouracil
Diasio, R. B., & Harris, B. E. (1989) · Clinical Pharmacokinetics · doi:10.2165/00003088-198916040-00002 · Cited by 969
Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease
Bartzokis, G. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.03.001 · Cited by 968
Research works printed but not linked: 3
- Silverman DH, Dy CJ, Castellon SA, Lai J, Pio BS, Abraham L, Waddell K, Petersen L, Phelps ME, Ganz PA: Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy. Breast Cancer Res Treat. 2007, 103: 303-311. 10.1007/s10549-006-9380-z. · DOI · Paper page
- Raimondi AJ, Tomita T: Advantages of 'total' resection of medulloblastoma and disadvantages of full head postoperative radiation therapy. Childs Brain. 1979, 5: 550-551.
- Cankaya H, Oner AF, Egeli E, Caksen H, Uner A, Akcay G: Auditory brainstem response in children with iron deficiency anemia. Acta Paediatr Taiwan. 2003, 44: 21-24.
Cited by
Items 101–200 of 317
Hyrien, O., Dietrich, J., & Noble, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1400 · Cited by 41
Self-citationStrategies to minimize CNS toxicity:in vitrohigh-throughput assays and computational modeling
Wager, T. T., Liras, J. L., Mente, S., & Trapa, P. E. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.677028 · Cited by 38
Glioma stem cell signaling: therapeutic opportunities and challenges
Dietrich, J., Diamond, E. L., & Kesari, S. (2010) · Expert Review of Anticancer Therapy · doi:10.1586/era.09.190 · Cited by 39
Self-citationYap, N. Y., Tan, N. Y. T., Tan, C. J., Loh, K. W.-J., Ng, R. C. H., Ho, H. K., & Chan, A. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05807-y · Cited by 40
Sirichoat, A., Suwannakot, K., Chaisawang, P., Pannangrong, W., Aranarochana, A., Wigmore, P. M., & Welbat, J. U. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117468 · Cited by 38
Neurological complications of pediatric cancer
Armstrong, C., & Sun, L. R. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09847-0 · Cited by 41
Fremouw, T., Fessler, C. L., Ferguson, R. J., & Burguete, Y. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.09.013 · Cited by 37
Synergetic Effect of SLN-Curcumin and LDH-5-Fu on SMMC-7721 Liver Cancer Cell Line
Zhu, R., Wu, X., Yu, X., Gao, B., Xie, Q. R., Liu, H., & Wang, S. (2013) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2012.1445 · Cited by 35
Kovalchuk, A., Rodriguez‐Juarez, R., Ilnytskyy, Y., Byeon, B., Shpyleva, S., Melnyk, S., Pogribny, I. P., Kolb, B. E., & Kovalchuk, O. (2016) · Aging · doi:10.18632/aging.100920 · Cited by 40
Oculomotor Deficits after Chemotherapy in Childhood
Einarsson, E.-J., Patel, M., Petersen, H., Wiebe, T., Magnusson, M., Moëll, C., & Fransson, P.-A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147703 · Cited by 31
Seo, E., Klauck, S. M., Efferth, T., & Panossian, A. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.10.022 · Cited by 31
Witlox, L., Schagen, S. B., de Ruiter, M. B., Geerlings, M. I., Peeters, P. H. M., Koevoets, E. W., van der Wall, E., Stuiver, M. M., Sonke, G. S., Velthuis, M. J., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-028117 · Cited by 34
Cognitive complications of cancer and cancer-related treatments – Novel paradigms
Lomeli, N., Lepe, J. J., Gupta, K., & Bota, D. A. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135720 · Cited by 36
Zhang, F., Chen, H., Zhang, R.-X., Liu, Y., Kong, N., Guo, Y., & Xu, M. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165884 · Cited by 32
Anderson, J. E., Trujillo, M., McElroy, T., Groves, T. R., Alexander, T. C., Kiffer, F. C., & Allen, A. R. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz213 · Cited by 30
Chang, D., Jung, J.-H., Kim, A. A., Marasini, S., Lee, Y. J., Paek, S. H., Kim, S., & Suh‐Kim, H. (2020) · PubMed Central · Cited by 27
Neurological complications following treatment of children with brain tumors
Monje, M., & Fisher, P. G. (2011) · Journal of Pediatric Rehabilitation Medicine · doi:10.3233/prm-2011-0150 · Cited by 27
Janelsins, M. C., Heckler, C. E., Thompson, B. D., Gross, R. A., Opanashuk, L. A., & Cory‐Slechta, D. A. (2016) · NeuroToxicology · doi:10.1016/j.neuro.2016.06.013 · Cited by 29
Rezaei, S. J. T., Malekzadeh, A. M., Ramazani, A., & Niknejad, H. (2019) · Current Drug Delivery · doi:10.2174/1567201816666191002102353 · Cited by 26
Ibrahim, O., Hogan, S. R., & Dover, J. S. (2020) · Advances in Cosmetic Surgery · doi:10.1016/j.yacs.2020.01.001 · Cited by 26
Utama, K., Khamto, N., Meepowpan, P., Aobchey, P., Kantapan, J., Sringarm, K., Roytrakul, S., & Sangthong, P. (2022) · Molecules · doi:10.3390/molecules27041154 · Cited by 26
Koppelmans, V., Schagen, S. B., Poels, M. M. F., Boogerd, W. J., Seynaeve, C., van der Lugt, A., & Breteler, M. M. B. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.06.026 · Cited by 28
Adverse Effects of 5-fluorouracil: Focus on Rare Side Effects
(2016) · Cancer Cell & Microenvironment · doi:10.14800/ccm.1266 · Cited by 26
Assessment of Cognitive Impairment and Complaints in Individuals With Colorectal Cancer
Visovatti, M. A., Reuter‐Lorenz, P. A., Chang, A. E., Northouse, L., & Cimprich, B. (2016) · Oncology nursing forum · doi:10.1188/16.onf.43-02ap · Cited by 27
Impact of Cognitive Impairment in Patients with Gliomas
Allen, D., & Loughan, A. R. (2018) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2018.10.010 · Cited by 31
Han, C., Li, Y., Sun, M., Liu, C., Ma, X., Yang, X., Yuan, Y., & Pan, W. (2013) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2013.801848 · Cited by 24
Gmeiner, W. H., Tomé, C. M. L., Gibo, D. M., Jennings‐Gee, J. E., Milligan, C., & Debinski, W. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1321-1 · Cited by 24
Li, T.-Y., Chen, V., Yeh, D., Huang, S.-L., Chen, C.-N., Chai, J., Chen, C., & Weng, J.-C. (2018) · BMC Cancer · doi:10.1186/s12885-018-5113-z · Cited by 24
Krynetskiy, E. Y., Krynetskaia, N. F., Rihawi, D., Wieczerzak, K., Ciummo, V., & Walker, E. A. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.03.013 · Cited by 25
Prospective assessment of white matter integrity in adult stem cell transplant recipients
Correa, D. D., Wang, Y., West, J. D., Peck, K. K., Root, J. C., Baser, R. E., Thaler, H. T., Shore, T. B., Jakubowski, A. A., Saykin, A. J., et al. (2015) · Brain Imaging and Behavior · doi:10.1007/s11682-015-9423-3 · Cited by 23
Shiroishi, M. S., Gupta, V., Bigjahan, B., Cen, S., Rashid, F. M., Hwang, D., Lerner, A., Boyko, O. B., Liu, C. J., Law, M., et al. (2017) · International Symposium on Medical Information Processing and Analysis (SIPAIM) · doi:10.1117/12.2285971 · Cited by 22
Sahayaraj, K., Kumar, V., & Avery, P. B. (2014) · European Journal of Entomology · doi:10.14411/eje.2015.020 · Cited by 22
Cognitive Effects of Cancer Treatment: "Chemo Brain" Explained
Evens, K., & Eschiti, V. S. (2009) · Clinical journal of oncology nursing · doi:10.1188/09.cjon.661-666 · Cited by 24
Cognitive impairments and cancer chemotherapy: Translational research at a crossroads
Evenden, J. L. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.03.020 · Cited by 29
Frontiers in targeting glioma stem cells
Fròsina, G. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.11.017 · Cited by 23
Dahhan, N. Z. A., Cox, E., Nieman, B. J., & Mabbott, D. (2022) · Neuron · doi:10.1016/j.neuron.2022.04.009 · Cited by 25
Savu, D., & Moisoi, N. (2022) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2022.148588 · Cited by 22
Kiesl, D., Kuzdas‐Sallaberger, M., Fuchs, D., Brunner, S. M., Kommenda, R., Tischler, C., Hornich, H., Akbari, K., Kellermair, J., Blessberger, H., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.777808 · Cited by 23
Capecitabine-induced acute toxic leukoencephalopathy
Obadia, M., Leclercq, D., Wasserman, J., Damien Galanaud, E., Dormont, D., Sahli-Amor, M., Psimaras, D., Pyatigorskaya, N., & Law-Ye, B. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2017.05.001 · Cited by 19
Noble, M., Mayer‐Pröschel, M., Li, Z., Dong, T., Cui, W., Pröschel, C., Ambeskovic, I., Dietrich, J., Han, R., Yang, Y. M., et al. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.10.860 · Cited by 19
Self-citationMEK1/2 Inhibition Suppresses Tamoxifen Toxicity on CNS Glial Progenitor Cells
Chen, H.-Y., Yang, Y. M., Han, R., & Noble, M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2729-13.2013 · Cited by 18
Self-citationHanding Off Critically Ill Patients to Family Caregivers
Alspach, G. (2009) · Critical Care Nurse · doi:10.4037/ccn2009467 · Cited by 18
Capecitabine-induced leukoencephalopathy involving the bilateral corticospinal tracts
Tan, M. B., & McAdory, L. E. (2016) · Journal of Radiology Case Reports · doi:10.3941/jrcr.v10i3.2686 · Cited by 19
Histone deacetylase inhibition is cytotoxic to oligodendrocyte precursor cells in vitro and in vivo
Dincman, T. A., Beare, J. E., Ohri, S. S., Gallo, V., Hetman, M., & Whittemore, S. R. (2016) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2016.08.006 · Cited by 19
Evaluation of the Cytotoxic Effects of CAM Therapies: AnIn VitroStudy in Normal Kidney Cell Lines
Arora, S., Tandon, C., & Tandon, S. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/452892 · Cited by 20
Corley, C. L., McElroy, T., Sridharan, B., Trujillo, M., Simmons, P., Kandel, S., Sykes, D. J., Robeson, M. S., & Allen, A. R. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1212791 · Cited by 20
Decreased postural control in adult survivors of childhood cancer treated with chemotherapy
Einarsson, E.-J., Patel, M., Petersen, H., Wiebe, T., Fransson, P.-A., Magnusson, M., & Moëll, C. (2016) · Scientific Reports · doi:10.1038/srep36784 · Cited by 17
Ganti, V., Walker, E. A., & Nagar, S. (2013) · Biomedical Chromatography · doi:10.1002/bmc.2893 · Cited by 17
Lyros, E., Walter, S., Keller, I., Papanagiotou, P., & Fassbender, K. C. (2014) · NeuroToxicology · doi:10.1016/j.neuro.2014.02.010 · Cited by 17
Axon–glia interactions in the ascending auditory system
Kohrman, D. C., Borges, B. C., Cassinotti, L. R., Ji, L., & Corfas, G. (2021) · Developmental Neurobiology · doi:10.1002/dneu.22813 · Cited by 17
Kašnar-Šamprec, J., Ratkaj, I., Mišković, K., Pavlak, M., Lončar, M. B., Pavelić, S. K., Glavaš‐Obrovac, L., & Žinić, M. (2011) · Investigational New Drugs · doi:10.1007/s10637-011-9657-x · Cited by 17
Evaluation of Multiple Neurotoxic Outcomes in Cancer Chemotherapy
Weiss, B. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6306-2_13 · Cited by 16
Guimarães, I. D. S., Daltoé, R. D., Herlinger, A. L., Madeira, K. P., Ladislau, T., Valadão, I. C., Junior, P. C. M. L., Teixeira, S. F., Modesto, G., dos Santos, D. Z., et al. (2013) · InTech eBooks · doi:10.5772/55282 · Cited by 18
Du, W., Li, C., Wang, H., Zhao, A., Shen, J., Yong, F., & Jia, H. (2015) · PubMed Central · Cited by 15
Neurocognitive Function in Adult Cancer Patients
Harrison, R. A., & Wefel, J. S. (2018) · Neurologic Clinics · doi:10.1016/j.ncl.2018.04.014 · Cited by 16
Yu, Q., Zhong, X., Chen, B., Yu, F., Ma, M., Diamond, C. A., Voeller, J., Kim, M. Y., DeSantes, K. B., Capitini, C. M., et al. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00291 · Cited by 15
Thermo-responsive nano-in-micro particles for MRI-guided chemotherapy
Zhang, Z., Wang, Y., Rizk, M. M. I., Liang, R., Wells, C. J. R., Gurnani, P., Zhou, F., Davies, G., & Williams, G. R. (2022) · Biomaterials Advances · doi:10.1016/j.msec.2022.112716 · Cited by 15
Is Systemic Anti-Cancer Therapy Neurotoxic? Does Chemo Brain Exist? And Should We Rename It?
Taillibert, S. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6306-2_12 · Cited by 15
Is There Evidence for Myelin Modeling by Astrocytes in the Normal Adult Brain?
Varela‐Echavarría, A., Vargas‐Barroso, V., Lozano‐Flores, C., & Larriva-Sahd, J. A. (2017) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2017.00075 · Cited by 12
Kimura, Y., Hayashi, Y., Hitomi, S., Ikutame, D., Urata, K., Shibuta, I., Sakai, A., Ni, J., Iwata, K., Tonogi, M., et al. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.10.013 · Cited by 17
Stevens, B. M., Folts, C. J., Cui, W., Bardin, A. L., Walter, K. A., Carson-Walter, E. B., Vescovi, A. L., & Noble, M. (2014) · Stem Cells · doi:10.1002/stem.1644 · Cited by 18
Self-citationAging in Adult Survivors of Childhood Cancer: Implications for Future Care
Schuitema, I., Alexander, T. C., Hudson, M. M., Krull, K. R., & Edelstein, K. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.02534 · Cited by 14
Accidental and experimentally induced 5‐fluorouracil toxicity in dogs
Sayre, R. S., Barr, J. W., & Bailey, E. M. (2012) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/j.1476-4431.2012.00783.x · Cited by 13
Sharpe, M. J., Fardell, J. E., Vardy, J. L., & Johnston, I. N. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.11.005 · Cited by 17
Chiang, M.-H., Chang, L.-W., Wang, J.-W., Lin, L.-C., & Tsai, T. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/729679 · Cited by 13
Gomaa, I. E. O., Gaber, S. A. A., Bhatt, S., Liehr, T., Glei, M., El-Tayeb, T. A.-A., & Abdel‐Kader, M. H. (2015) · Journal of Nanoparticle Research · doi:10.1007/s11051-015-2912-x · Cited by 13
Sabet, M., & Ganji, M. D. (2013) · Journal of Molecular Modeling · doi:10.1007/s00894-013-1936-3 · Cited by 13
Jenkins, V. A., Low, R., & Mitra, S. S. (2009) · The Breast · doi:10.1016/j.breast.2009.07.004 · Cited by 13
Kovalchuk, A., Ilnytskyy, Y., Rodriguez‐Juarez, R., Katz, A. M., Sidransky, D., Kolb, B. E., & Kovalchuk, O. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00058 · Cited by 13
Schroyen, G., Schramm, G., Weehaeghe, D. V., Leenaerts, N., Casteele, T. V., Blommaert, J., Koole, M. J. B., Smeets, A., Laere, K. V., Sunaert, S. G., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1021615 · Cited by 13
Zhang, Y., Yi, X., Gao, J., Li, L., Liu, L., Qiu, T. H., Zhang, J., Zhang, Y., & Liao, W. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00567 · Cited by 12
Exercise May Affect Metabolism in Cancer-Related Cognitive Impairment
Shahid, M., & Kim, J. (2020) · Metabolites · doi:10.3390/metabo10090377 · Cited by 14
Canertinib induces ototoxicity in three preclinical models
Tang, J., Qian, Y., Li, H., Kopecky, B. J., Ding, D., Ou, H. C., DeCook, R. R., Chen, X., Sun, Z.-Y. J., Kobel, M. J., et al. (2015) · Hearing Research · doi:10.1016/j.heares.2015.07.002 · Cited by 16
Elyan, S. S., Elsayed, M., ashraf, N., Sayed, N., Saleh, M., Osama, M., Ahmed, S., Gadelmawla, M. H. A., & Alam-ElDein, K. M. (2026) · Nano-Structures & Nano-Objects · doi:10.1016/j.nanoso.2026.101697 · Cited by 10
Bradley-Garcia, M., Winocur, G., & Sekeres, M. J. (2022) · Cancers · doi:10.3390/cancers14194752 · Cited by 13
Ormiston, K., Melink, Z., Andridge, R., Lustberg, M. B., DeVries, A. C., Murphy, K., Emmers, K., Ziouzenkova, O., Belury, M. A., & Orchard, T. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.09.021 · Cited by 10
Weng, Q., Tan, B., Wang, J., Wang, J., Zhou, H., Shi, J., He, Q., & Yang, B. (2014) · Toxicology · doi:10.1016/j.tox.2014.08.011 · Cited by 14
Wang, J., Bushman, J. S., Wang, X., Mayer‐Pröschel, M., Johnson, M. D., & Noble, M. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0546-13.2013 · Cited by 11
Self-citationJacob, A., Veedu, J. S., Selene, I. I., Raj, R., Kannan, L., & Patel, R. A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.977734 · Cited by 10
Martuscello, R. T., Reynolds, B. A., & Kesari, S. (2016) · Springer eBooks · doi:10.1007/978-1-4899-7654-3_18 · Cited by 10
Bougea, A. M., Voskou, P., Kilidireas, C., & Andreadou, E. (2016) · Case Reports in Oncological Medicine · doi:10.1155/2016/2408269 · Cited by 9
Neuropsychological Consequences for Survivors of Childhood Brain Tumor in Malaysia
Alias, H., Lau, S. C. D., Schuitema, I., & de Sonneville, L. M. J. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.00703 · Cited by 11
Recent and remote spatial memory in mice treated with cytosine arabinoside
Fremouw, T., Fessler, C. L., Ferguson, R. J., & Burguete, Y. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.10.008 · Cited by 11
Fluorouracil-induced leukoencephalopathy mimicking neuroleptic malignant syndrome: a case report
Hemachudha, P., Rattanawong, W., Pongpitakmetha, T., & Phuenpathom, W. (2023) · Journal of Medical Case Reports · doi:10.1186/s13256-023-03814-3 · Cited by 8
Review of the fluoropyrimidine antidote uridine triacetate
Thompson, J., Wood, D. M., & Dargan, P. I. (2024) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.16319 · Cited by 10
Zhang, H., Li, P., Liu, T., Wang, X., Feng, W. G., Chen, R., Wei, H., Li, G., Ning, L., Zhang, M., et al. (2021) · Brain Imaging and Behavior · doi:10.1007/s11682-021-00551-3 · Cited by 8
The histological and histochemical changes of the rat's liver induced by 5- fluorouracil
Al-Hamdany, M. Z., & Al-Hubaity, A. I. M. (2014) · Al-mağallaẗ al-ʻirāqiyyaẗ li-l-ʻulūm al-bayṭariyyaẗ/Iraqi journal of veterinary sciences · doi:10.33899/ijvs.2014.116958 · Cited by 8
Effects of prenatal exposure to cancer treatment on neurocognitive development, a review
Vercruysse, D., Deprez, S., Sunaert, S. G., Calsteren, K. V., & Amant, F. C. (2016) · NeuroToxicology · doi:10.1016/j.neuro.2016.02.013 · Cited by 10
Walker, E. A. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6306-2_18 · Cited by 8
The Biological Intersection Between Chemotherapy-Related Cognitive Impairment and Alzheimer Disease
Torre, M., Zanella, C. A., & Feany, M. Β. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.12.013 · Cited by 8
Microglia‐Mediated Synaptic Dysfunction Contributes to Chemotherapy‐Related Cognitive Impairment
Wang, J., Zhang, H., Augenreich, M. A., Luis Martinez‐Lemus, A., Liu, Z., Kang, X., Lu, B., Chang, H., Yeh, E. T. H., Cata, J. P., et al. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70024 · Cited by 8
Kuil, L. E., Coppola, N., Dietrich, J., & Castel, H. (2025) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2025.2539199 · Cited by 8
Self-citationNeuropsychology of Chemotherapy in Brain Tumor Patients
Loughan, A. R., Allen, D., Ah, D. M. V., & Braun, S. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812100-9.00062-0 · Cited by 9
Srivastava, R. K., & Singh, P. (2020) · Regenerative Medicine · doi:10.2217/rme-2020-0060 · Cited by 8
Huangteerakul, C., Aung, H. M., Thosapornvichai, T., Duangkaew, M., Jensen, A. N., Sukrong, S., Ingkaninan, K., & Jensen, L. T. (2021) · Molecules · doi:10.3390/molecules26051207 · Cited by 8
Delayed Neurologic Complications of Brain Tumor Therapy
Dietrich, J., Winter, S. F., & Parsons, M. W. (2019) · Springer eBooks · doi:10.1007/978-3-030-04152-6_42 · Cited by 7
Self-citationAzali, N. S., Kamarudin, N. H. N., Jaafar, J. A., Timmiati, S. N., & Sajab, M. S. (2020) · Materials Today Proceedings · doi:10.1016/j.matpr.2020.09.693 · Cited by 7
Willie, Y. B. A., Gunawan, M., Hadad, Y., Ramadon, D., Saputri, F. C., Jansook, P., Boonkanokwong, V., & Iswandana, R. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107319 · Cited by 7
Challenges in research on the neural basis of „chemobrain”
Kaiser, J., & Dietrich, J. (2014) · Translational Neuroscience · doi:10.2478/s13380-014-0223-9 · Cited by 6
Self-citationWang, N., Wang, T., Wang, M., Hao, A., & Li, T. (2011) · Journal of Liquid Chromatography & Related Technologies · doi:10.1080/10826076.2011.583372 · Cited by 6
Metadata
- Authors
- Han, R., Yang, Y. M., Dietrich, J., Luebke, A., Mayer-Pröschel, M., & Noble, M.
- Affiliations
- University of Rochester Medicine (US)
- Corresponding author
- Noble, Mark
- Venue
- Journal of Biology
- Published
- 2008-04-22
- Volume
- 7
- Issue
- 4
- Pages
- 12-12
- ISSN
- 1475-4924 (ISSN-L)
- PMC
- PMC2397490
- OpenAlex
- W2152709121
- Cited by
- 316
- References
- 203
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 8 · 2023: 10 · 2022: 21 · 2021: 22 · 2020: 20 · 2019: 16 · 2018: 17 · 2017: 14 · 2016: 25 · 2015: 16 · 2014: 26 · 2013: 25 · 2012: 18
- FWCI
- 18.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
- Locations
- Journal of Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Institute on Deafness and Other Communication Disorders (R01DC003086)
- National Institute of Neurological Disorders and Stroke (R01NS044701, NS44701)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD39702, R01HD039702)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- 5-fluorouracil, chemotherapy-induced neurotoxicity, white matter degeneration, myelin pathology, transcriptional regulation, auditory system, central nervous system
- MeSH terms
- Action Potentials, Animals, Antineoplastic Agents, Auditory Pathways, Bromodeoxyuridine, Central Nervous System, Fluorouracil, Humans, Indoles, Microscopy, Fluorescence, Myelin Sheath, Stem Cells, Tetrazolium Salts, Thiazoles, In Situ Nick-End Labeling, Cell Line, Tumor, Microscopy, Electron, Transmission, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.